- Country: USA
- Summary: Limited Competition: Aids Malignancy Consortium (Amc; Um1 Clinical Trial Required)
- UST Ref No: 105768519
- Deadline: 10 Jan 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: RFA-CA-24-028
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Through This Notice Of Funding Opportunity (Nofo), The National Cancer Institute (Nci) Intends To Enable The Provision Of Support For Aids Malignancy Consortium (Amc). Amc Is A Major Infrastructure Intended To Stimulate Cooperative Research Efforts In The Following Areas: Design, Development, And
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINLimited Competition: Aids Malignancy Consortium (Amc; Um1 Clinical Trial Required) - USA Tender
The NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Limited Competition: Aids Malignancy Consortium (Amc; Um1 Clinical Trial Required). This tender is published on USARFP under UST Ref No: 105768519 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-01-10.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
